Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences — Audrey Bellesœur (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences
Shared by
David M. Smadja
Université René Descartes (Paris V)
Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences
Article
2018
en
Authors
+13 more
AB
Audrey Bellesœur
AB
Audrey Bellesœur
AT
Audrey Thomas‐Schoemann
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Management of Thrombosis in High-Risk Patients: Focus on Cancer-Associated Thrombosis
Mari Thomas
,
Paula Bolton‐Maggs
,
Giancarlo Agnelli
Article
2014
Direct Oral Anticoagulants in Patients With VTE and Cancer
Maria Cristina Vedovati
,
Federico Germini
,
Giancarlo Agnelli
,
Cecilia Becattini
Article
2021
Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants
Yi‐Hsin Chan
,
Tze‐Fan Chao
,
Hsin‐Fu Lee
,
Shao‐Wei Chen
,
Pei‐Ru Li
,
Jia‐Rou Liu
,
Lung‐Sheng Wu
,
Shang‐Hung Chang
,
Yung‐Hsin Yeh
,
Chi‐Tai Kuo
,
Lai‐Chu See
,
Professor Gregory Lip
Article
2021
Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
Yu‐Sheng Lin
,
Feng‐Che Kuan
,
Tze‐Fan Chao
,
Michael Wu
,
Shao‐Wei Chen
,
Mien‐Cheng Chen
,
Chang‐Ming Chung
,
Pao‐Hsien Chu
,
Professor Gregory Lip
,
Victor Chien‐Chia Wu
Article
2023
The association between HbA1c variability and strokes in patients receiving anticoagulants
Jiayi Huang
,
Chanchal Chandramouli
,
Mei‐Zhen Wu
,
Q W Ren
,
Hung‐Fat Tse
,
Professor Gregory Lip
,
Kai Hang Yiu
Discussion(0)
No comments yet. Be the first to comment.